> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Stimwave Mobile Platform Cleared for Pain Device
- URL: https://www.fdaweb.com/stimwave-mobile-platform-cleared-for-pain-device/
- Published: 2018-10-31T12:00:00.000Z
- Updated: 2026-09-15T00:41:43.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5142717

FDA has cleared a Stimwave Technologies 510(k) for the WaveCrest Mobile iOS Platform patient controllers for opioid-free pain management. This clearance gives patients iPhone and Apple Watch mobile control over the company’s multi-waveform automated programming for the Wireless Freedom Spinal Cord Stimulator (SCS) System for chronic pain relief, according to the company. It says this is the first FDA-cleared software that allows the AppleWatch to control a neuromodulation device implanted inside the body. The software is designed to be easy to use and secure, Stimwave says, adding that it also enables pain sufferers to fine-tune the power level, visualize battery life, and modify programs that were pre-programmed by their clinician to control pain without opioids.